Lupin LimitedNSE: LUPIN

Press Release Aug 24 2021

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated August 24, 2021, titled "Lupin Launches Luforbec�� 100/6 μg pMDI, first branded generic alternative to Fostair�� 100/6 μg pMDI for treatment of Asthma & COPD, in the UK.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases